Therapeutic Potential of Peroxisome Proliferator-Activated Receptor Modulation in Non-Alcoholic Fatty Liver Disease and Non-Alcoholic Steatohepatitis

Therapeutic Potential of Peroxisome Proliferator-Activated Receptor Modulation in Non-Alcoholic Fatty Liver Disease and Non-Alcoholic Steatohepatitis

A long neglected hepatic manifestation of the metabolic syndrome, non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH) arise as serious health burden with alarming global prevalence. The disease complex is currently attracting considerable interest of drug discovery and...

Full description

Bibliographic Details
Main Authors: Leonie Gellrich, Daniel Merk
Format: Article
Language:English
Published: KenzPub 2017-12-01
Series:Nuclear Receptor Research
Subjects:
non-alcoholic fatty liver disease (NAFLD)
non-alcoholic steatohepatitis (NASH)
peroxisome proliferator-activator receptor (PPAR)
metabolic diseases
drug discovery
fatty liver
nuclear receptors
lipid metabolism
Online Access:http://www.kenzpub.com/journals/nurr/2017/101310/

Internet

http://www.kenzpub.com/journals/nurr/2017/101310/

Similar Items